𝛼SK or Search

ENTITY

Zhaoke Ophthalmology (6622 HK)

35

Analysis

Health Care • China

Zhaoke Ophthalmology is an ophthalmic pharmaceutical company focused on the research, development, manufacturing, and commercialization of therapies for unmet medical needs in eye diseases. Its comprehensive drug portfolio addresses conditions such as dry eye disease, myopia, presbyopia, wet age-related macular degeneration, diabetic macular edema, and glaucoma. The company was founded in 2017 and is headquartered in Guangzhou, China.

more

Refresh

Exchange Announcement • 30 Sep 2026 16:46

2026 Interim Report

Exchange Announcement • 30 Sep 2026 15:07

Notification Letter To Registered Shareholders And Reply Form

Exchange Announcement • 30 Sep 2026 15:07

Notification Letter To Non-Registered Shareholders And Reply Form

Exchange Announcement • 04 Sep 2026 18:38

Voluntary Announcement - Carbachol And Brimonidine Tartrate Ophthalmic Solution (Yuvezzi) Met The Primary Endpoint In The Phase Ii Study In Chinese Patients With Presbyopia

Exchange Announcement • 28 Aug 2026 21:15

Interim Results Announcement For The Six Months Ended June 30, 2026

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x